The study indicated the long-term effectiveness and safety of InterStim in patients with fecal incontinence of more than twice per week.
At three years, 86 percent of subjects had at least a 50 percent reduction in incontinent episodes and 40 percent had perfect continence.
Read the Diseases of the Colon & Rectum report on InterStim Therapy for incontinence.
Related Articles on Incontinence:
First Artificial Sphincter Could Treat Fecal, Urinary Incontinence
FDA Approves Solesta to Treat Life-Altering Fecal Incontinence
FDA Gastroenterology and Urology Device Panel Approves Fecal Incontinence Product
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
